ANGO
AngioDynamics·NASDAQ
--
--(--)
--
--(--)
ANGO Filings
Filing Date
Form Description
Form Type
2026-03-26
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-26 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-10
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-10 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-09
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-09 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-01-14
Form 8-K - Current report
Key Events
2026-01-14 · Key Events
Form 8-K - Current report
2026-01-08
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-08 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-06
AngioDynamics, Inc.(ANGO)-20260106-2026 Q2 Earnings call transcript
Earnings Call
2026-01-06 · Earnings Call
AngioDynamics, Inc.(ANGO)-20260106-2026 Q2 Earnings call transcript
2026-01-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-01-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-01-06
Form 8-K - Current report
Key Events
2026-01-06 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
